CXCL12 and cancer: Lin et al., using spheroid models with PDAC cancer cells derived from KPC tumor-bearing mice, found that cancer cells resistant to a T-cell attack in vitro (which were tumor-educated T cells obtained from draining lymph nodes of tumor-bearing mice) universally had a decreased expression of CXCL12 [162].